Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›Oncotarget›Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers

Science & Medicine

Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers

Oncotarget by Oncotarget Podcast

Sep 9, 202600:06:42Science & Medicine

BUFFALO, NY – September 9, 2026 – A new was in Volume 17 of Oncotarget on September 8, 2026, titled “Re-expression of MHC-I to treat CNS cancers.” The review examines emerging strategies to restore major histocompatibili...

Related Episodes

Continue listening to more episodes from Oncotarget.

Molecular Tumor Board Maps Precision Treatment Options for a Woman With Multiple Primary Cancers

Oct 20, 2026 - 00:17:02

When one person develops several cancers over the course of many years, treatment decisions can become in...

Pan-Cancer Analysis Identifies Buckwheat-Derived Compound as Potential AKT1 Drug-Design Candidate

Oct 14, 2026 - 00:08:26

BUFFALO, NY – October 14, 2026 – A new paper was in Volume 17 of on October 12, 2026, titled “Integrative...

Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer

Oct 6, 2026 - 00:14:04

Cancer cells often survive by disrupting the molecular pathways that normally eliminate damaged or abnorm...

Gut Microbiome Emerges as a Potential Partner in Precision Cancer Therapy

Sep 28, 2026 - 00:06:09

BUFFALO, NY – September 28, 2026 – A new was in Volume 17 of Oncotarget on September 23, 2026, titled “Gu...

DHHC3 Helps Melanoma Tumors Evade Antitumor Immunity

Sep 23, 2026 - 00:11:16

Cancer cells do not grow in isolation. Their ability to survive and form tumors depends partly on how the...

Commentary Calls for Consistent Evaluation of Potential Links Between COVID-19, Vaccination and Cancer

Sep 17, 2026 - 00:02:02

BUFFALO, NY – September 17, 2026 – A new was in Volume 17 of Oncotarget on September 11, 2026, titled “Ar...

Therapeutic HPV Vaccine PepCan Tested for Preventing Head and Neck Cancer Recurrence

Sep 8, 2026 - 00:12:46

Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation,...

Oncotarget Supports WIN 2026 Symposium Advancing Precision Oncology

Sep 8, 2026 - 00:02:33

BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the...